Month: September 2020

미국 노스캐롤라이나주 롤리/오하이오주 콜럼버스, Sept. 19, 2020 (GLOBE NEWSWIRE) — PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ:PRAH))는 종양 임상시험에 참가할 환자 액세스 및 모집을 활성화하기 위해 새로운 전략적 협력관계를 구축한다고 밝혔다. 이번 관계를 통해 암 환자에 대한 식별, 스크리닝, 매칭 작업을 향상시키는 최고 수준의 기술들을 결합해 정밀의료 기반 종양 임상시험을 글로벌 단위로 실시할 수 있을 전망이다. 통합된 솔루션은 Microsoft Azure를 통해 도입된다.수상 경력에 빛나는 Deep Lens의 VIPERTM 환자 스크리닝 플랫폼은 여러 암 센터, 통합 이송망(IDN), 커뮤니티 종양 네트워크들이 도입한 혁신적 기술이다. 자칫 누락되어 임상시험 등록 기회를 놓칠 수 있는 종양 환자를 식별해 생명을 구할 수 있는 임상시험에 매칭시킨다. Deep Lens는 차별화된 기술과 서비스 모델을 바탕으로 자사 소프트웨어를 전 세계 암 센터와 현장 네트워크에 무료로 공급하고 있다. 이를 통해 환자들이 자신에게 반드시 필요한 각종 치료법에 액세스할 수 있도록 한다. 또한 연구 타임라인을 가속화하고 업계 판도를 뒤바꿀 다양한 치료법을 더 빨리 시장에 선보일 수 있게 함으로써 커다란 가치를 공급한다.켄트 토엘케(Kent Thoelke) PRA 헬스사이언스 최고과학책임자는 “1만 4,000건이 넘는 종양 임상이 현재 환자를 모집 중에 있지만, 이 가운데 환자가 실제로 참여하는 경우는 3~5% 정도에 불과하다”면서 “임상시험은 환자 모집 과정에서 다양한 문제들이 불거져 나오며, 의뢰자들은 시험 매칭을 위한 특정 환자들의...

RALEIGH, N.C. dan COLUMBUS, Ohio, Sept. 19, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) dan Deep Lens, Inc. mengumumkan hubungan strategik baharu hari ini untuk mempercepat akses dan perekrutan pesakit untuk percubaan klinikal onkologi. Hubungan ini menyatukan teknologi terbaik dalam kelasnya yang meningkatkan pengenalpastian, penyaringan dan pemadanan pesakit kanser untuk percubaan onkologi klinikal berasaskan ketepatan dengan penyelesaian gabungan yang dikerahkan kepada Microsoft Azure.Platform penyaringan pesakit Deep Lens yang memenangi anugerah, iaitu VIPER™ merupakan teknologi cemerlang yang dikerahkan oleh pusat kanser, rangkaian penghantaran bersepadu (IDN) serta rangkaian onkologi komuniti untuk mengenal pasti dan memadankan pesakit onkologi dengan percubaan klinikal penyelamatan nyawa yang jika tidak,...

RALEIGH, N.C. e COLUMBUS, Ohio, Sept. 18, 2020 (GLOBE NEWSWIRE) — A PRA Health Sciences, Inc. (NASDAQ: PRAH) e Deep Lens, Inc., anunciaram hoje uma nova relação estratégica para acelerar o acesso e o recrutamento de pacientes para ensaios clínicos oncológicos. A parceria reúne as melhores tecnologias da categoria que aprimoram a identificação, triagem e correspondência dos pacientes com câncer com ensaios clínicos oncológicos com base em precisão em todo o mundo, com a solução combinada sendo implantada no Microsoft Azure.A premiada plataforma VIPERTM da Deep Lens de triagem de pacientes, é uma tecnologia inovadora implantada por centros de câncer, redes de entrega integradas (IDNs) e redes comunitárias de oncologia para identificar e combinar pacientes oncológicos com ensaios clínicos que podem salvar vidas que normalmente são...

RALEIGH, Carolina del Norte y COLUMBUS, Ohio, Sept. 18, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) y Deep Lens, Inc., anunciaron hoy una nueva alianza estratégica para acelerar el acceso y el reclutamiento de pacientes para ensayos clínicos oncológicos. La alianza integra las mejores tecnologías en su categoría desarrolladas para mejorar la identificación, selección y emparejamiento de pacientes con cáncer para ensayos clínicos oncológicos basados en precisión en todo el mundo, con la solución combinada implementada en Microsoft Azure.La galardonada plataforma de detección de pacientes VIPERTM de Deep Lens es una tecnología innovadora implementada por centros oncológicos, redes de parto integradas (IDN) y redes oncológicas comunitarias para identificar y emparejar a pacientes oncológicos con ensayos clínicos...

SEATTLE, Sept. 18, 2020 (GLOBE NEWSWIRE) — Sound Financial Bancorp, Inc. (Nasdaq: SFBC) (the “Company”), the parent company of Sound Community Bank (the “Bank”), today announced the completion of a private placement of $12.0 million in aggregate principal amount of 5.25% Fixed-to-Floating Rate Subordinated Notes due 2030 (the “Notes”). The Company intends to use the proceeds of the private placement for general corporate purposes.The Notes will initially bear interest at a fixed rate of 5.25% per annum from September 18, 2020 to October 1, 2025, with interest during this period payable semiannually in arrears. From October 1, 2025 to the stated maturity date or early redemption date, the interest rate will reset quarterly to an annual floating interest rate equal to Three-Month Term Secured Overnight Financing Rate plus 513 basis...

NASHVILLE, Tenn., Sept. 18, 2020 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE: HR) today announced that it will redeem all of its outstanding 3.75% Senior Notes due 2023 (the “Notes”) in accordance with the terms of the indenture governing the Notes. The Company intends to use the net proceeds from the issuance of its 2.05% senior notes due 2031 to fund the redemption. The Company’s 2.05% senior notes due 2031 are expected to be issued on October 2, 2020, subject to customary closing conditions. The Company expects to record a charge in the fourth quarter of 2020 of approximately $21.5 million for early extinguishment of the Notes, which includes approximately $1.1 million of unamortized costs and discounts.The Company will redeem the Notes on October 18, 2020 (the “Redemption Date”) at a redemption price equal...

NASHVILLE, Tenn., Sept. 18, 2020 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE: HR) today announced that it has agreed to sell $300 million of 2.05% senior unsecured notes due March 2031 in an underwritten public offering. The notes were priced at 99.189% of the principal amount to yield 2.137% to maturity. Subject to customary closing conditions, the offering is expected to close on October 2, 2020.The estimated net proceeds from this offering are expected to be $294.8 million. The Company expects to use the net proceeds from the offering to redeem the Company’s 3.75% senior notes due 2023 and for other general corporate purposes, which may include payments toward the Company’s unsecured credit facility due 2023, its unsecured term loan due 2024, its unsecured term loan due 2026, and/or various mortgage...

VANCOUVER, British Columbia, Sept. 18, 2020 (GLOBE NEWSWIRE) — Aben Resources Ltd. (TSX-V: ABN) (OTCBB: ABNAF) (Frankfurt: E2L2) (the “Aben or the Company”) is pleased to announce it has closed a non-brokered private placement financing for total gross proceeds of CAD $153,499.94 (the “Placement”).The Company has allotted and issued 1,395,454 units (the “Units”) at a price of CAD $0.11 per Unit. Each Unit is comprised of one common share and one transferable warrant (the “Warrants”). Each Warrant will entitle the holder to purchase one additional common share for a period of two (2) years at a price of CAD $0.15 per share.In addition, the Company has paid finder’s fees of $1,540 and issued 14,000 finder’s warrants (the “Finders Warrants”) to an arm’s-length party. Each Finders Warrant is exercisable into one common share for a period...

CALGARY, Alberta, Sept. 18, 2020 (GLOBE NEWSWIRE) — New Millennium Iron Corp. (the “Company” or “NML”) (TSX: NML) is pleased to announce, further to the previously announced reorganization with the Tata Steel Group, that it has arrived at an agreement with Abaxx Technologies Inc. (“Abaxx”) to enter into an business combination agreement (the “Agreement”). Under the terms of the Agreement, NML and Abaxx will effect a transaction that will result in a reverse takeover of NML by the shareholders of Abaxx (the “Transaction”) to ultimately form the resulting issuer (“Resulting Issuer”), subject to the terms and conditions outlined below. Upon completion of the Transaction, it is the intention of the parties that the Resulting Issuer will continue the business of Abaxx. The Resulting Issuer will apply to list on the TSX Venture Exchange...

LIVERMORE, Calif., Sept. 18, 2020 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq:FORM) is pleased to announce its participation in the following investor conference:Sidoti & Company, LLC 2020 Investor ConferenceDate: September 24th, 2020Presentation Time: 12:15 pm EDTThe public is invited to listen to a live webcast of FormFactor’s presentation, which can be accessed from the investors’ section of the company’s website at www.formfactor.com. Replay of the webcast will also be available at www.formfactor.com.About FormFactor:FormFactor, Inc. (NASDAQ:FORM), is a leading provider of essential test and measurement technologies along the full IC life cycle – from inspection and metrology, characterization, modeling, reliability, and design de-bug, to qualification and production test. Semiconductor companies...